Abuse of buprenorphine

Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England.

The International journal on drug policy·2022

Undetected Respiratory Depression in People with Opioid Use Disorder.

Drug and alcohol dependence·2022

Mobile telephone delivered contingency management for encouraging adherence to supervised methadone consumption: feasibility study for an RCT of clinical and cost-effectiveness (TIES).

Pilot and feasibility studies·2021

Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management.

Contemporary clinical trials·2018

Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors.

AIDS care·2015

Compressed opiate withdrawal syndrome and naltrexone.

Journal of psychopharmacology (Oxford, England)·2012

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Encephalopathy following subcutaneous administration of Brixadi® extended-release buprenorphine.

Toxicology reports·2026

Systematic understanding of acute effects of dexmedetomidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation.

American journal of physiology. Regulatory, integrative and comparative physiology·2026

A Micellar Electrokinetic Chromatography Screening Tool for Antiepileptic Drugs.

Electrophoresis·2026

In vivo evaluation of the dual MOP/NOP agonist AT121: a potent analgesic that delays opioid tolerance and offers a superior withdrawal suppression profile to methadone.

Neuroscience·2026

Identification of a Benzenesulfonylpiperazine Derivative With In Vivo Efficacy Against Visceral Leishmaniasis.

Chemical biology & drug design·2026

[Pharmacodynamic material basis and mechanism of Baoyuan Decoction in treating chronic obstructive pulmonary disease].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026

Related Experiment Videos

Abuse of buprenorphine

Related Concept Videos

Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England.

Undetected Respiratory Depression in People with Opioid Use Disorder.

Mobile telephone delivered contingency management for encouraging adherence to supervised methadone consumption: feasibility study for an RCT of clinical and cost-effectiveness (TIES).

Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management.

Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors.

Compressed opiate withdrawal syndrome and naltrexone.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Encephalopathy following subcutaneous administration of Brixadi® extended-release buprenorphine.

Systematic understanding of acute effects of dexmedetomidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation.

A Micellar Electrokinetic Chromatography Screening Tool for Antiepileptic Drugs.

In vivo evaluation of the dual MOP/NOP agonist AT121: a potent analgesic that delays opioid tolerance and offers a superior withdrawal suppression profile to methadone.

Identification of a Benzenesulfonylpiperazine Derivative With In Vivo Efficacy Against Visceral Leishmaniasis.

[Pharmacodynamic material basis and mechanism of Baoyuan Decoction in treating chronic obstructive pulmonary disease].

Related Experiment Videos

Abuse of buprenorphine

Related Concept Videos

Related Articles